美股A股
StockGist
Back
6-K2026-04-29· deepseek-chat

MDXH · MDxHealth S.A.

0001213900-26-049539

SEC filing

Summary

MDxHealth proposes to issue 3,000,000 warrants to Exact Sciences and 3,000,000 share options to personnel, and renew authorized capital up to 100% for five years.

Key takeaways

Full analysis

The filing details proposals for MDxHealth's extraordinary general meeting on May 28, 2026. Key items include issuing 3,000,000 warrants to Exact Sciences at $5.265 per share, exercisable until January 8, 2031, with a minimum aggregate exercise price of $500,000. These warrants are non-transferable and not listed. Additionally, 3,000,000 share options are proposed for personnel under the 2026 Share Option Plan, with a ten-year term. The board also seeks renewal of authorized capital to increase share capital by up to 100% for five years, allowing restriction of preemptive rights. These proposals aim to provide financing flexibility and employee incentives. Shareholder approval requires a 75% majority and 50% quorum for extraordinary items. The registration date is May 22, 2026, with notification by May 26, 2026.